Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

1177-1188 of 1735 results
Page 99 of 145
Key Publications April 15, 2016

Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study.

BMJ. 2016;352:i721

Jousilahti P, Laatikainen T, Peltonen M, Borodulin K, Männistö S, Jula A, Salomaa V, Harald K, Puska P, Vartiainen E
Cardiovascular Disease Epidemiology Prevention
Key Publications April 15, 2016

Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke-Blood Pressure) randomised controlled trial.

BMJ. 2016;352:i708

Mant J, McManus RJ, Roalfe A, Fletcher K, Taylor CJ, Martin U, Virdee S, Greenfield S, Hobbs FD
Cardiovascular Disease Hypertension Prevention
Key Publications April 14, 2016

Alternative strategies to achieve cardiovascular mortality goals in China and India: A microsimulation of target- versus risk-based blood pressure treatment.

Circulation. 2016;133:840-8

Basu S, Yudkin JS, Sussman JB, Millett C, Hayward RA
Cardiovascular Disease Hypertension Prevention
Key Publications April 14, 2016

Changes in body mass index and obesity risk in married couples over 25 years: The ARIC Cohort Study.

Am J Epidemiol. 2016;183:435-43

Cobb LK, McAdams-DeMarco MA, Gudzune KA, Anderson CA, Demerath E, Woodward M, Selvin E, Coresh J
Epidemiology Obesity Prevention
Expert Opinions April 13, 2016

Could you describe the large research group that you have federated in Winnipeg and what are its key objectives?

Jonathan McGavock, PhD, Associate Professor, Department of Pediatrics and Child Health, Faculty of Medicine, Manitoba Institute of Child Health, University of Manitoba; CIHR Applied Public Health Chair in Resilience and Childhood Obesity, Winnipeg, MB, CA
Diabetes Prevention
Key Publications April 13, 2016

Novel approaches in primary cardiovascular disease prevention: The HOPE-3 Trial rationale, design, and participants' baseline characteristics.

Can J Cardiol. 2016;32:311-8

Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A et al.
Cardiovascular Disease Clinical Trials Prevention
Key Publications April 12, 2016

Tribulations of recent cardiology trials, the Audacity of Hope, and HOPE-3.

Can J Cardiol. 2016;32:275-7

Waters DD, Chau KH
Cardiovascular Disease Clinical Trials Prevention
Key Publications April 12, 2016

Healthy lifestyle factors and incident heart disease and mortality in candidates for primary prevention with statin therapy.

Int J Cardiol. 2016;207:196-202

Booth Iii JN, Colantonio LD, Howard G, Safford MM, Banach M, Reynolds K, Cushman M, Muntner P
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications April 11, 2016

Association between a healthy heart score and the development of clinical cardiovascular risk factors among women: Potential role for primordial prevention.

Circ Cardiovasc Qual Outcomes. 2016;9:S77-85

Sotos-Prieto M, Mattei J, Hu FB, Chomistek AK, Rimm EB, Willett WC, Eliassen AH, Chiuve SE
Cardiovascular Disease Epidemiology Prevention
Key Publications March 29, 2016

Trends in ideal cardiovascular health metrics among employees of a large healthcare organization (from the Baptist Health South Florida Employee Study).

Am J Cardiol. 2016;117:787-93

Ogunmoroti O, Utuama O, Spatz ES, Rouseff M, Parris D, Das S, Younus A, Guzman H, Tran T, Agatston A, Feldman T, Virani SS, Maziak W, Veledar E, Nasir K
Cardiovascular Disease Epidemiology Prevention
Key Publications March 28, 2016

Obesity: we need to move beyond sugar.

Lancet. 2016;387:199

The Lancet
Nutrition Obesity Prevention
Key Publications March 28, 2016

A test in context: high-sensitivity C-reactive protein.

J Am Coll Cardiol. 2016;67:712-23

Ridker PM
Cardiovascular Disease Inflammation Prevention
of 145